The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
VANCOUVER, BRITISH COLUMBIA–(Marketwired – June 20, 2016) – GoviEx Uranium Inc. (CSE:GXU) announced that, pursuant to its Stock Option Plan, it has granted incentive stock options to certain directors, officers, employees and consultants to purchase up to an aggregate of 10,535,000 common shares in the capital stock of the company. The options are exercisable at …
VANCOUVER, BRITISH COLUMBIA–(Marketwired – June 20, 2016) – GoviEx Uranium Inc. (CSE:GXU) announced that, pursuant to its Stock Option Plan, it has granted incentive stock options to certain directors, officers, employees and consultants to purchase up to an aggregate of 10,535,000 common shares in the capital stock of the company.
The options are exercisable at a price of $0.12 per share and will vest 25% on the date of grant, with an additional 25% vesting on each anniversary of the date of grant thereafter until fully vested. The options expire on June 20, 2021.
About GoviEx Uranium Inc.
GoviEx is a mineral resource company focused on the exploration and development of its African uranium properties. GoviEx’s principal objective is to become a significant uranium producer through the continued exploration and development of its Mine Permitted Madaouela Project in Niger and its Mine Permitted Mutanga Project in Zambia and Falea Project in Mali.
Visit GoviEx’s website at www.goviex.com.
The options are exercisable at a price of $0.12 per share and will vest 25% on the date of grant, with an additional 25% vesting on each anniversary of the date of grant thereafter until fully vested. The options expire on June 20, 2021.
About GoviEx Uranium Inc.
GoviEx is a mineral resource company focused on the exploration and development of its African uranium properties. GoviEx’s principal objective is to become a significant uranium producer through the continued exploration and development of its Mine Permitted Madaouela Project in Niger and its Mine Permitted Mutanga Project in Zambia and Falea Project in Mali.
Visit GoviEx’s website at www.goviex.com.
GoviEx Uranium Inc.
Govind Friedland
Executive Chairman
+1 604 331-9882GoviEx Uranium Inc.
Daniel Major
Chief Executive Officer
+1 604 331-9882
GoviEx Uranium Inc.
Bill Trenaman
Investor Relations
+1 604 331-9882
info@goviex.com
www.goviex.com
Govind Friedland
Executive Chairman
+1 604 331-9882GoviEx Uranium Inc.
Daniel Major
Chief Executive Officer
+1 604 331-9882
GoviEx Uranium Inc.
Bill Trenaman
Investor Relations
+1 604 331-9882
info@goviex.com
www.goviex.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.